Copegus (Genentech, Inc.)
Welcome to the PulseAid listing for the Copegus drug offered from Genentech, Inc.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | Ribavirin |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-12-03 |
END MARKETING DATE: | 0000-00-00 |
Copegus HUMAN PRESCRIPTION DRUG Details:
Item Description | Copegus from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2002-12-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0086_b6c64bc6-3918-427c-8ef2-bd7ab7ce01c8 |
PRODUCT NDC: | 0004-0086 |
APPLICATION NUMBER: | NDA021511 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: